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cleoside nephrosis.
Areas of the glomerular basement membrane (GBM)
Background. Our previous work in the acute puromycin not covered by podocytes appear to be the major sites aminonucleoside nephrosis (PAN) model has demonstrated of protein loss in studies using tracers. The ultrastructural up-regulation of heparin-binding epidermal growth factor-like appearance of foot process effacement is also seen in all growth factor (HB-EGF) mRNA and protein within glomerular epithelial cells (GECs) prior to the onset of proteinuria.
diseases causing nephrotic-range proteinuria, although
Methods. To determine whether increased HB-EGF expresthe importance of podocyte effacement in the genesis of sion in the acute PAN model contributes to the pathogenesis proteinuria is not clear [1] . The most important adhesion of proteinuria, a monoclonal antibody (DE10) was produced molecule involved in maintenance of normal podocyte against recombinant human HB-EGF. morphology appears to be the ␤ 1 -integrin, VLA-3 [2, 3] .
Results. The specificity of DE10 for human HB-EGF was VLA-3 is also connected through a series of intracellular confirmed by enzyme-linked immunosorbent assay, immunomolecules (for example, vinculin, paxilin, and talin) to histochemical staining, and flow cytometry of transfected cells expressing human and rat HB-EGF, and inhibition of cell prothe cytoskeleton. Disruption of the connection between liferation. DE10 also reacted with cells transfected with rat VLA-3 on the cell surface and F-actin microfilaments HB-EGF cDNA. Administration of 0.5 mg affinity-purified inside the cell may be one mechanism by which foot DE10 to normal rats did not cause significant albuminuria process effacement occurs, a process suggested by studies compared with controls. Five days after the induction of the of VLA-3 knockout mice [4] . acute PAN model, albuminuria was significantly greater in VLA-3 has been shown to associate on the cell surface animals treated with 0.5 mg DE10 than a control mAb (162.6 Ϯ 32.4 vs. 64.8 Ϯ 10.2 mg/day, respectively, P Ͻ 0.01). Rats treated with heparin-binding epidermal growth factor-like growth with DE10 had an earlier onset of severe albuminuria, but no factor (HB-EGF) [5, 6] . Most normal glomeruli do not increase in maximal albuminuria at later time points. Electron express HB-EGF mRNA or protein at levels detectable microscopy showed marked podocyte effacement in both by in situ hybridization or immunohistochemistry [7] [8] [9] . DE10-treated and control animals, but no obvious difference Prior to the onset of proteinuria in the acute puromycin between groups. However, adhesion of the human GEC line aminonucleoside nephrosis (PAN) and passive Heymann 56/10 A1 to laminin and fibronectin, but not to collagens I or IV, was reduced by DE10. nephritis models, however, HB-EGF mRNA and protein
Conclusions. This study suggests that HB-EGF contributes are easily detectable in podocytes [7] . In view of the close to the integrity of the glomerular filtration barrier, particularly association between HB-EGF and VLA-3, it is possible when the podocyte has been injured. Following podocyte inthat increased expression of HB-EGF could modify the jury, adhesion to laminin in the glomerular basement memfunction of VLA-3 in disease, influencing the onset of brane by HB-EGF may be important in reducing albuminuria.
proteinuria. In this study, therefore, we have produced a mouse monoclonal antibody (mAb) against HB-EGF to determine its role in the pathogenesis of acute proteinuria. . Antibody was used as spent hybridoma supernatants or purified ascitic fluid. Antibody subclass was struct pHB-EGF.hu. pHB-EGF.rat was produced by first amplifying the coding sequence of rat HB-EGF using the determined by Ouchterlony immunodiffusion using a commercial mouse mAb typing kit (The Binding Site, primers 5Ј-ACCATGAAGCTGCTGCCGTC-3Ј and 5Ј-CATAGTCTGTTTGGCACTTAGAGGC-3Ј and subBirmingham, UK).
cloning this into pGEM-T (Pharmacia). The fragment Production and purification of ascitic fluids was sequenced to confirm its identity, and the insert was then excised and subcloned into pcDNA-3 to create Female Balb/c mice aged five months or more were used to produce ascitic fluids. 2,6,10,14-TetramethylpenpHB-EGF.rat. For transfection, 2.2 ϫ 10 5 cells/well were plated into tadecane (0.5 mL; Pristane; Sigma Chemical Co., St. Louis, MO, USA) was injected intraperitoneally on two six-well tissue culture plates in 2 mL of complete media in a CO 2 incubator at 37ЊC. Cells were incubated for 18 occasions, seven days apart, followed by 1 to 5 ϫ 10 6 hybridoma cells three days after the second injection.
hours until 60% confluent. Two solutions were prepared: 2 mg of plasmid DNA were dissolved in 100 L serumMice were inspected daily for abdominal swelling and were sacrificed before there was evidence of distress.
free medium (Opti-MEM 1 reduced serum medium), and 12 L of lipofectamine (Life Technologies, GaithersAscitic fluids were collected by laparotomy, allowed to clot overnight, and further purified by ammonium sulfate burg, MD, USA) were dissolved in 100 L serum-free medium. The two solutions were mixed gently and left precipitation. Thereafter, mouse IgG was purified by affinity chromatography on a HiTrap protein G column at room temperature for 15 minutes; 0.8 mL of serumfree DMEM was then added to the mixed solution and (Pharmacia Biotech, Uppsala, Sweden). The purified mAb was dialyzed against phosphate-buffered saline overlaid onto washed cells for five hours at 37ЊC in the incubator. One milliliter of DMEM containing 20% fetal (PBS) prior to use. Purity of the affinity-purified mAb was confirmed by sodium dodecyl sulfate-polyacrylcalf serum (FCS) was added, and the medium was replaced 24 hours later. For creation of stable transfectants, amide gel electrophoresis (SDS-PAGE).
cells were selected in G418 and assayed when stable cell ELISA for the detection of antibodies against EGF lines emerged. and related proteins Immunohistochemical staining of a transfected cell line Enzyme-linked immunosorbent assay (ELISA) was performed as described by Engvall and Perlman [12] .
NIH-3T3 cells were transiently transfected with pHB-EGF.hu or vector control using lipofectamine as deBriefly, flat-bottomed PVC plates (Dynatech Laboratories Ltd., VA, USA) were coated with recombinant huscribed earlier. The cells were stained with the mAb DE10 using a three-step method. Briefly, the cells were man HB-EGF, or the related proteins betacellulin (BTC), amphiregulin (AR), EGF, and transforming growth facgrown on cover slips and fixed in acetone for five minutes at 4ЊC. DE10 as culture supernatant was added and incutor-␣ (TGF-␣), by overnight incubation with the protein in carbonate buffer, pH 9.6. Plates were blocked with 1% bated for one hour at 37ЊC followed by 30 minutes with a secondary antibody, rabbit anti-mouse Ig (Dako, Carbovine serum albumin (BSA)/PBS. Hybridoma supernatants were used undiluted. Antibody binding was detected pinteria, CA, USA) at 1:20 dilution and a further 30 minutes with APAAP complex (Dako) at 1:40 dilution. using anti-mouse immunoglobulin coupled to horseradish peroxidase. Plates were developed using o-phenylenedi-
The slides were then developed in alkaline phosphatase substrate solution (Sigma) for 20 minutes and counterSraer. Twenty-four-well tissue culture plates were coated with the relevant protein through the addition of stained with hematoxylin and Scott's tap water.
100 L of a 10 g/mL solution and incubation for two Coupling of mAb to fluorescein isothiocyanate hours at 37ЊC. The following extracellular matrix constituents were used; bovine collagen I (Vitrogen; Collagen DE10 was purified with a protein-G column prior to conjugation. The antibody was dialyzed overnight Corporation, Palo Alto, CA, USA), mouse type IV collagen IV (Life Technologies), human placental laminin against two to three changes of pH 9.5 carbonate/bicarbonate buffer (8.6 g NaCO 3 and 17.2 g NaHCO 3 -1 L (Sigma), and bovine plasma fibronectin (ICN Biomedicals Inc., Aurora, OH, USA). Nonspecific adhesion was H 2 O). The concentration of the protein was measured by optimal density at 280 nm, and 1 mg/mL of protein was blocked by incubating the plates in 1% bovine serum albumin in PBS at 4ЊC overnight. Cell monolayers were used for conjugation. Fluorescein isothiocyanate (FITC) was dissolved in dimethyl sulfoxide (DMSO) to 10 radiolabeled with 3 H-thymidine (2.5 mCi/mL) overnight and then briefly trypsinized. The cells were resuspended mg/mL, and 100 g were then added to the purified mAb dropwise, with stirring. The reaction was allowed in RPMI media containing 1% fetal calf serum and incubated with the monoclonal antibodies DE10, OX-34 to proceed for two hours shielded from light. After conjugation, excess dye was removed by gel filtration on Seph-(Serotec Ltd., Kidlington, Oxford, UK), or anti-CD49c (the ␣ chain of VLA-3) antibody (11G5; Serotec) at 4 adex G-25 (PD10 columns from Pharmacia) in PBS containing 0.1% NaN 3 . The absorbance of each conjugate g/mL for approximately 15 minutes. The radiolabeled cells were then added to the wells at 1 ϫ 10 5 cells/well was measured at 280 nm, and the conjugated antibody was stored at 4ЊC, protected from light.
and then incubated at 37ЊC for one hour to allow the initial attachments to form. Unattached cells were reFlow cytometry moved by washing with PBS, and the attached cells were solubilized in 1 mol/L NaOH. Incorporation of the 3 HTransfected cells were trypsinized and washed with PBS before incubating with FITC-labeled DE10, no antithymidine was determined using a cell harvester and liquid scintillation ␤-counter, as before. Results are exbody, and an irrelevant FITC-conjugated antibody for 30 minutes on ice. After washing the cells with PBS, the pressed as the percentage of binding compared with the no-antibody control. cells were resuspended in 400 L of PBS and analyzed using a flow cytometer (FACSCalibur; Becton DickinThe acute PAN model son, Sunnyvale, CA, USA).
Acute PAN was induced in 150 to 170 g Sprague-
Cell proliferation assay
Dawley rats using an established protocol [7] by a single intravenous injection of 15 mg/100 g PAN (Sigma). At Two ϫ 10 4 NIH-3T3 cells were placed in each well of 24-well tissue culture plates (Flow Laboratories, least six rats were used per group. McLean, VA, USA) and allowed to adhere for 24 hours Administration of mAb to rats in 10% FCS in RPMI 1640. The cells were growth arrested for 48 hours in RPMI 1640 and then incubated Male Sprague-Dawley rats (150 to 170 g) were injected intravenously with a single dose of 0.5 mg of DE10, the with one of the following recombinant human growth factors; HB-EGF, EGF, BTC, AR, and TGF-␣. Growth irrelevant mAb RMAC 8 (IgG2a), or saline. For rats with PAN, the antibody was administered the day following factors were all used at 10 ng/mL.
3 H-thymidine 3 mCi (New England Nuclear, Boston, MA, USA) and the antiinjection of PAN. Urine was collected for 16 hours in metabolic cages. Albuminuria was measured by radial body test reagents at 1 mg/mL were also added at the same time. Cultures were incubated for 24 hours at 37ЊC immunodiffusion using commercial plates incorporating an anti-rat albumin antibody (rat/mouse albumin NL in 5% CO 2 . The cell layers were then washed, harvested with 200 L NaOH, and harvested onto glass fiber filter RID plates; The Binding Site). paper using a cell harvester (Inotech Cell Harvester SysDetection of DE10 in the serum of normal rats tem; Inotech Biosystems International, Rockville, MD, USA). The filter paper from each well harvested was Male Sprague-Dawley rats (N ϭ 3) weighing approximately 150 g were injected intravenously with 0.5 mg then mixed with 50 L liquid scintillant, and specific activity was counted using a ␤ counter (Packard Tri-DE10. Blood was collected at various times, and the injected DE10 was detected in rat serum using ELISA. Carb 1600CA).
Briefly, plates were coated with 10 g/mL goat antiCell adhesion assays mouse Ig, blocked, and then reacted with diluted (1:400) rat serum collected between days 0 and 35. Noninjected Cell adhesion assays were performed as described by Chakravarti, Tam, and Chung using the human GEC rats were also included as controls. Plates were then incubated with biotinylated swine anti-mouse Ig folline 56/10 A1 [13, 14], a generous gift of Professor J.D. lowed by Streptavidin peroxidase. Peroxidase labeling was revealed using OPD. The reaction was stopped using 4 mol/L sulfuric acid and absorbances read at 492 nm on an ELISA plate reader (Behring). Known concentrations of the injected antibody were used to generate a standard curve and the concentration of DE10 in rat serum calculated.
Fluorescence microscopy
Following induction of the PAN model of proteinuria, rats weighing approximately 150 g were injected intravenously with 1.5 mL saline, RMAC 8 0.5 mg, or DE10 0.5 mg, and then were sacrificed three days later. Kidneys were harvested and snap frozen in liquid nitrogen, and 4 m cryostat sections were prepared and fixed in icecold acetone for 10 minutes at 4ЊC. The sections were at room temperature and then stained using anti-WT-1 rabbit polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at a final concentration of 1 g/mL. Sections were washed in PBS and then stained found to be IgG2a. In ELISA, DE10 was strongly posiwith Oregon Green-conjugated goat anti-mouse antitive against rhHB-EGF but did not react with rhEGF, body at a final concentration of 5 g/mL (Molecular rhTGF-␣, rhAR, or rhBTC (Fig. 1) . Reactivity with HBProbes, Eugene, OR, USA) and Texas red-X conjugated EGF was confirmed by immunohistochemical staining goat anti-rabbit antibody at a final concentration of 2 of NIH-3T3 cells transiently transfected with a construct g/mL (Molecular Probes). Sections were comprehencontaining human HB-EGF cDNA (pHB-EGF.hu) using sively washed in PBS and then mounted with fluorescent the APAAP technique (Fig. 2) . Cells transfected with a mounting medium (Dako). Images were collected and vector control were negative. Moreover, FITC-conjugenerated on a confocal laser scanning microscope (Biogated DE10 also reacted in flow cytometry with CHO Rad MRC 1024; Bio-Rad Microscopy Division, Hemel cells stably transfected with pHB-EGF.hu (Fig. 3A) . Hempstead, Herts, UK).
DE10 also bound Cos cells stably transfected with a construct encoding rat HB-EGF (pHB-EGF.rat) by flow Transmission electron microscopy cytometry (Fig. 3B) . In both of these assays, DE10 did Tissue was immersion fixed in 2.5% glutaraldehyde not bind cells transfected with a vector control. for two hours, postfixed in 1% osmium tetroxide, dehydrated in graded acetones, and embedded in Epon-AralFunctional activity of DE10 dite. Sections (0.08 ) were cut and stained with uranyl To determine whether DE10 inhibited the functional acetate and lead citrate and examined in a Phillips CM12 activity of HB-EGF, DE10 or an irrelevant mAb of the electron microscope.
same isotype was added to NIH-3T3 cells stimulated with HB-EGF, EGF, TGF-␣, AR, or BTC. Cell proliferStatistics ation was measured by incorporation of 3 H-thymidine. Statistics were performed using the Instat software There was significant inhibition of cell proliferation when package, version 2.01, from GraphPad Software. Multithe cells were treated with DE10 and stimulated with ple comparisons were performed using analysis of vari-HB-EGF, but not with an irrelevant mAb (Fig. 4) . Also, ance (ANOVA), followed by the Tukey-Cramer multi-DE10 had no effect when cells were stimulated with ple comparison test. A P value Ͻ0.05 was considered other members of the EGF family. Interestingly, inhibisignificant. tion of proliferation with DE10 was not complete, despite an approximately tenfold molar excess.
RESULTS

Treatment of rats with DE10 Production and characterization of mAb DE10
The serum half-life of DE10 in normal rats, following A total of 1540 wells were screened and 77 positive administration of 0.5 mg affinity-purified DE10, was wells obtained. The mAb DE10 was selected for cloning eight days (Fig. 5) . When administered to normal rats, because it was the only antibody that could be shown to stain tissue sections by immunohistochemistry. It was DE10 did not produce significant albuminuria. When mals were complement-depleted using cobra venom factor (CVF) administered on alternate days and then treated with DE10 after induction of the PAN model, as before. Complement depletion was checked prior to administration of each dose by CH 50 and was found to Localization of DE10 in the kidneys of treated rats by administered the day following injection of PAN 15 laser scanning confocal microscopy mg/kg, there was an earlier onset of proteinuria (Fig. 6 ), commencing at day 3 compared with day 5 in the control Rats injected with PAN were treated on the following day (day 1) with saline (Fig. 7A) , the irrelevant mAb rats (Fig. 6B ), and a significantly greater level of proteinuria at day 5 (Fig. 6A) . By day 10, this had fallen to RMAC 8 (Fig. 7B ), or DE10 (Fig. 7C) , and sacrificed on day 4. Antibody detected in kidney sections were stained levels comparable with control animals. When DE10 was administered at day 5, however, there was no difference with anti-mouse Ig and the sections were costained with a rabbit polyclonal antibody directed against the podocyte in proteinuria five days later (data not shown). To determine whether the increase in proteinuria was due to marker WT1. Mouse Ig staining, in rats injected with RMAC 8, was localized predominantly to capillary loops complement-mediated injury to podocytes by DE10, ani- (Fig. 7B) . The same staining was seen in rats injected
We have previously described an increase in HB-EGF mRNA and protein in glomerular epithelial cells (GECs) with DE10, but in addition, there were cells that stained prior to the onset of proteinuria in both PAN and passive with both WT1 and anti-mouse Ig (Fig. 7C) , demonstraHeymann nephritis [7] . The function of increased HBting that DE10 localized specifically to podocytes.
EGF in this location is unknown, but we proposed that Electron microscopy of kidneys from rats treated it might contribute to the onset of proteinuria, either with DE10
through stimulation of abortive mitogenesis of GEC with subsequent detachment from the GBM or binding of To determine whether the severity of proteinuria at HB-EGF to the GBM, so altering its filtration properties. day 5 was reflected by a difference in morphology, groups Therefore, it was surprising that administration of DE10 of three animals with PAN, which received either RMAC increased proteinuria early in the course of the PAN 8 or DE10 at day 1 postinduction, were killed at days 3 model, suggesting that up-regulation of HB-EGF was and 5, and the kidneys were fixed for electron microsacting to decrease proteinuria. The findings did not apcopy. The appearances of the kidney at day 3 were similar pear to be due to complement-mediated injury to GEC in both groups, although focal foot process effacement because administration of cobra-venom factor did not and mild swelling of podocytes were only apparent in the affect the result. There are at least three potential explaanimals that received DE10; the animals that received nations for these observations. RMAC 8 showed relatively normal glomerular morpholFirst, there is evidence that the recirculation of albuogy at this stage ( Fig. 8 A, B) . However, at day 5, both min in the glomerular filtrate through the proximal tugroups showed widespread severe effacement of foot bule may be considerable. It has been estimated that 1.8 processes, associated with extensive swelling, vacuolamg/min of albumin per rat kidney may recirculate in this tion and protein droplet accumulation within the cytoway (abstract; Eppel et al, J Am Soc Nephrol 9:337A, plasm of podocytes ( Fig. 8 C, D) . There was no apparent 1998). It is possible that blocking HB-EGF interferes difference between those animals administered RMAC 8 with this pathway. However, this appears an unlikely and no evidence of podocyte detachment from the gloexplanation, because administration of DE10 had no merular basement membrane in either group.
effect on the level of proteinuria in the PAN model when Inhibition of cell adhesion using DE10 administered at day 5 after induction. If the pathway was blocked, then this should increase proteinuria irreAdhesion of 56/10 A1 cells to laminin and fibronectin spective of the time of administration. was significantly inhibited by DE10 (Fig. 9 ), but binding A second potential explanation relies on the ability of to collagen I and collagen IV was not affected. Inhibition the transmembrane form of HB-EGF to inhibit apoptoof binding with the positive control mAb against the sis in epithelial cells. This observation was made by Ta-␣-subunit of VLA-3 (CD49c) was as predicted from pubkemura et al in the renal tubular epithelial cell line NRK lished specificity of VLA-3. The only difference between 52E [15]. Since so-called "bare areas" of the GBM are DE10 and the mAb against VLA-3 was the inability of the reported to be the site of greatest passage of tracer DE10 to inhibit binding to collagen I. molecules in PAN [16, 17] , up-regulation of HB-EGF may prevent detachment of GEC because of cell injury, DISCUSSION and thus reduce the bare areas. This explanation appears The mAb DE10 was made against recombinant human unlikely because we did not observe an increase in bare HB-EGF. It was found to be specific for human HBareas of the GBM in rats treated with DE10 compared EGF by ELISA, and reactivity with cells transfected with with controls, although these could be distributed in a expression constructs for both human and rat HB-EGF focal manner. cDNA. The antibody also inhibited function of recombiFinally, HB-EGF has been reported to associate with nant human HB-EGF, as assessed by inhibition of cell the integrin VLA-3 on the surface of various cell types. VLA-3 is the major integrin present on human GEC in proliferation. vivo, and there is increasing evidence that it is important EGF to increase cell survival in response to pro-apoptotic stimuli [15] or the adhesive properties of HB-EGF, in maintaining podocyte morphology through its contacts with actin microfilaments inside the cell. The funcdemonstrated in this article. Although the albuminuria observed in response to injection of DE10 in normal tion of the interaction between HB-EGF and VLA-3 is presently unknown. However, it is possible that HBglomeruli was minimal, it suggests that HB-EGF also has a role in maintaining the filtration barrier in normal EGF modifies the adhesive properties of VLA-3 and helps to maintain podocyte morphology. In these studies, glomeruli. Finally, DE10 is the first mAb reported against HBthe adhesive role of HB-EGF is further strengthened EGF. Its ability to bind both human and rat HB-EGF by the demonstration that the inhibitory mAb DE10
and to inhibit function suggests that it may be a useful reduced adhesion of the GEC line 56/10 A1 to fibronecreagent in defining the role of HB-EGF in kidney distin and laminin. Despite this finding in vitro, however, eases and other conditions, such as atherosclerosis, we were unable to demonstrate any difference in morwound healing, and cancer, where it has been identified phology between animals treated with DE10 or control as a potentially important growth factor. antibody.
The albuminuria that occurred after administration of ACKNOWLEDGMENTS DE10 to normal rats was relatively slight and separates this mAb from some others that produce massive pro-acute renal injury: Isolation and localization of bioactive molecules.
